3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Specimen Handling
4
Cyclophosphamide
4
Biopsy
4
Radiotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
sodium-iodide symporter
2
pembrolizumab
2
mogamulizumab
2
fludarabine phosphate
2
fludarabine
2
cemiplimab
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Immunoglobulin G
2
Disulfides
2
Busulfan
2
Brentuximab Vedotin
2
talimogene laherparepvec
1
ruxolitinib
1
hypericin
1
duvelisib
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
trastuzumab biosimilar HLX02
×
90 days
×
Clear all
No trials found.